Patents by Inventor Lior Rosenfeld

Lior Rosenfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HYPOALLERGENIC PEANUT ALLERGENS, PRODUCTION AND USE THEREOF
    Publication number: 20240117020
    Abstract: In one embodiment, the present disclosure provides a combination of recombinant Ara h 1 and Ara h 2 variant polypeptides lacking at least one epitope recognized by anti-Ara h 1 antibodies and anti-Ara h 2 antibodies, respectively, thereby having reduced or abolished antibody binding to the peanut allergen. These peanut allergen variants may be used in methods of treating subjects allergic to peanuts and reducing the severity of their allergy.
    Type: Application
    Filed: November 29, 2023
    Publication date: April 11, 2024
    Applicant: Ukko Inc.
    Inventors: Yanay OFRAN, Moshe BEN DAVID, Orly MARCU GARBER, Si NAFTALY KIROS, Gil DIAMANT, Almog BREGMAN COHEN, Maayan KORMAN, Anna CHUPRIN, Zohar BIRON SOREK, Lior ROSENFELD SHLAMKOVICH, Etai ROTEM, Yair GAT
  • COMPOSITIONS AND METHODS FOR TREATMENT OF BONE ASSOCIATED DISEASES
    Publication number: 20210403514
    Abstract: Mutant M-CSF protein, comprising ?v?3 integrin binding motif and pharmaceutical compositions comprising same, are provided. Further, use of the composition for the treatment and or prevention of diseases associated with increased bone resorption are provided.
    Type: Application
    Filed: August 4, 2021
    Publication date: December 30, 2021
    Applicants: THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD., B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
    Inventors: Niv PAPO, Noam LEVAOT, Yuval ZUR, Lior ROSENFELD
  • Compositions and methods for treatment of bone associated diseases
    Patent number: 11098091
    Abstract: Mutant M-CSF protein, comprising ?v?3 integrin binding motif and pharmaceutical compositions comprising same, are provided. Further, use of the composition for the treatment and or prevention of diseases associated with increased bone resorption are provided.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: August 24, 2021
    Assignees: THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD., B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
    Inventors: Niv Papo, Noam Levaot, Yuval Zur, Lior Rosenfeld